Suppr超能文献

120 个欧洲地区经皮冠状动脉介入治疗应用的持续地域差异:探索差异。

Persistent geographical disparities in the use of primary percutaneous coronary intervention in 120 European regions: exploring the variation.

机构信息

Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.

出版信息

EuroIntervention. 2013 Aug 22;9(4):469-76. doi: 10.4244/EIJV9I4A76.

Abstract

AIMS

Large inequalities in the use of primary percutaneous interventions (PPCI) for ST-elevation myocardial infarction (STEMI) are evident. In order to understand how we can help to implement best practice for STEMI patients, we investigated the variation in PPCI utilisation in 120 regions in 10 EU countries and the association with economic, organisational and demographic characteristics.

METHODS AND RESULTS

We performed an ecological study using mixed effects regression models in the following 10 countries: Austria, Belgium, Denmark, England and Wales, Germany, Italy, Portugal, Spain, Sweden, and Northern Ireland. The main finding was the annual number of PPCI per million inhabitants from 2003 through 2008. Overall, the annual increase in PPCI utilisation was 1.15 (95% CI: 1.12, 1.19) per million per year. Regional-level rates varied from 0.74 (95% CI: 0.42, 1.30) to 1.90 (95 % CI: 1.01, 3.55) per million per year. At a regional level, significant positive associations with PPCI utilisation were the number of physicians per 100,000 inhabitants; the number of nurses and midwives per 100,000 inhabitants; and the proportion of the region's population aged 50 to <70 years. At a country level, significant positive associations with utilisation were the year of STEMI treatment, population density per km2; number of general hospital beds per 100,000 inhabitants; and the number of physicians per 100,000 inhabitants.

CONCLUSIONS

Between 2003 and 2008, PPCI utilisation increased significantly in the ten European countries studied, but there was a great variation within country regions. Regional variation in PPCI rates were associated with both demographic and supply factors, revealing substantial opportunities to improve PPCI utilisation across Europe at national and regional levels.

摘要

目的

ST 段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗(PPCI)的应用存在较大差异。为了了解如何帮助实施 STEMI 患者的最佳实践,我们调查了 10 个欧盟国家的 120 个地区的 PPCI 使用情况的变化及其与经济、组织和人口统计学特征的关系。

方法和结果

我们在以下 10 个国家进行了一项生态学研究,使用混合效应回归模型:奥地利、比利时、丹麦、英格兰和威尔士、德国、意大利、葡萄牙、西班牙、瑞典和北爱尔兰。主要发现是 2003 年至 2008 年每百万居民每年的 PPCI 数量。总体而言,PPCI 使用率的年增长率为每百万每年 1.15(95%CI:1.12,1.19)。区域水平的利率从每百万 0.74(95%CI:0.42,1.30)到 1.90(95%CI:1.01,3.55)不等。在区域层面上,与 PPCI 使用相关的显著正相关因素包括每 10 万居民中的医生人数;每 10 万居民中的护士和助产士人数;以及该地区 50 至<70 岁人口的比例。在国家层面上,与使用率相关的显著正相关因素包括 STEMI 治疗的年份、每平方公里人口密度;每 10 万居民的综合医院床位数;以及每 10 万居民的医生人数。

结论

在 2003 年至 2008 年间,研究的十个欧洲国家的 PPCI 使用量显著增加,但国家内部区域之间存在很大差异。PPCI 率的区域差异与人口统计学和供应因素有关,这表明在国家和地区层面上,欧洲有很大的机会改善 PPCI 的使用率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验